Salsalate, an NF-κB inhibitor, can improve fasting plasma glucose, reduce HbA1c levels, and reduce proinflammatory markers in T2DM patients.641 A phase 2 study showed that salsalate can improve NCV. Here, NFKB1 is linked to type 2 diabetes mellitus.